Nutex Health Income Statement (2010-2026) | NUTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	62.81M	117.97M	63.40M	79.13M	58.05M	28.40M	53.72M	56.33M	58.92M	62.72M	69.67M	67.45M	76.08M	78.80M	257.62M	211.79M	243.99M	267.80M	151.68M	216.49M
Cost of Revenue (Quarter)	2.57M	4.94M	2.60M	4.26M	2.58M	2.49M	2.79M	4.02M	3.26M	3.46M	3.40M	5.32M	3.59M	3.98M	2.39M	3.80M	4.81M	3.31M	5.32M	4.01M
Gross Profit (Quarter)	29.14M	76.01M	19.49M	35.82M	6.64M	-26.47M	0.53M	4.85M	9.65M	7.07M	13.21M	10.16M	22.56M	21.92M	141.63M	118.34M	124.92M	154.88M	46.14M	91.73M
Operating items
Amortization - Intangibles (Quarter)	0.19M	0.19M	0.23M	0.22M
Depreciation & Amortization - Total (Quarter)
Research & Development (Quarter)	0.06M	0.07M	0.08M	0.07M
Selling, General & Administrative (Quarter)	1.53M	1.55M	0.39M	6.58M	4.08M	4.08M	6.31M	7.18M	9.76M	7.79M	8.50M	8.66M	10.65M	9.87M	12.75M	10.04M	12.50M	11.30M	17.82M	14.38M
Restructuring Costs (Quarter)			3.55M		3.89M		0.01M			0.04M	536.00
Other Operating Expenses (Quarter)	32.08M	-0.07M	39.89M	36.66M	43.45M			14.20M				48.64M	42.87M	47.01M	103.24M	27.64M	78.75M	101.63M	-174.60M	-3.92M
Operating Expenses (Quarter)	33.68M	1.55M	43.92M	43.31M	51.41M	402.21M	53.19M	51.48M	10.01M	7.89M	56.46M	57.30M	53.52M	56.88M	115.99M	37.68M	91.25M	112.92M	-156.78M	10.46M
Operating Income (Quarter)	27.60M	74.46M	15.54M	29.24M	-1.38M	-428.68M	-5.78M	-4.45M	-0.36M	-0.82M	-26.14M	1.45M	5.30M	9.66M	114.21M	80.66M	33.68M	130.37M	30.92M	81.27M
EBIT (Quarter)	27.60M	74.46M	15.54M	29.24M	-1.38M	-428.68M	-5.78M	-4.45M	-0.36M	-0.82M	-26.14M	1.45M	5.30M	9.66M	114.21M	80.66M	33.68M	130.37M	30.92M	81.27M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)	245.00	270.00	288.00	368.00
Other Non Operating Income (Quarter)	4.06M	1.75M	-0.24M	-2.38M	1.40M	0.63M	-0.21M	-0.25M	0.12M	0.05M	-0.33M	0.24M	0.60M	-0.13M	-0.04M	-3.33M	-4.27M	-0.98M	-0.05M	-0.02M
Non Operating Income (Quarter)	4.06M	1.75M	-0.24M	0.60M	8.28M	0.63M	-0.21M	-0.25M	7.24M	0.05M	-0.33M	0.24M	0.60M	6.42M	-0.04M	-3.33M	-4.27M	-0.98M	10.20M	13.28M
Net income details
EBT (Quarter)	30.16M	74.95M	13.35M	25.00M	-4.34M	-431.45M	-8.85M	-7.83M	-5.08M	-4.87M	-30.71M	-0.15M	3.90M	-2.58M	108.66M	71.22M	23.73M	123.94M	25.89M	76.56M
Tax Provisions (Quarter)	0.48M	0.45M	-0.13M	0.18M	19.65M	-8.54M	1.81M	-0.91M	-0.82M	-0.34M	-3.00M	0.39M	0.89M	4.58M	8.61M	20.41M	7.59M	27.14M	9.29M	13.80M
Profit After Tax (Quarter)	29.68M	74.49M	13.47M	24.83M	-24.00M	-422.91M	-10.66M	-6.92M	-4.27M	-4.52M	-27.71M	-0.54M	3.01M	-8.79M	99.97M	21.22M	16.14M	96.80M	121.40M	62.76M
Income from Non-Controlling Interests (Quarter)	2.62M	20.70M	-0.50M	-4.71M	-4.71M	-10.72M	4.09M	-1.77M	-0.79M	1.02M	3.91M	-0.18M	3.37M	1.62M	38.27M	29.59M	33.84M	41.36M	4.77M	15.96M
Income from Continuing Operations (Quarter)	29.68M	74.49M	13.47M	24.83M	-24.00M	-422.91M	-10.66M	-6.92M	-4.27M	-4.52M	-27.71M	-0.54M	3.01M	-7.17M	100.05M	50.81M	16.14M	96.80M	16.61M	62.76M
Consolidated Net Income (Quarter)				24.83M	-24.00M	-422.91M	-10.66M	-6.92M	-4.27M	-4.52M	-27.71M	-0.54M	3.01M	-7.17M	100.05M	50.81M	16.14M	96.80M	16.61M	62.76M
Income towards Parent Company (Quarter)				24.83M	-24.00M	-422.91M	-10.66M	-6.92M	-4.27M	-4.52M	-27.71M	-0.54M	3.01M	-7.17M	100.05M	50.81M	16.14M	96.80M	16.61M	62.76M
Net Income towards Common Stockholders (Quarter)	23.71M	53.79M	65.42M	7.18M	-19.40M	-422.52M	9.93M	-6.92M	-4.27M	-4.52M	-27.71M	-0.36M	3.01M	-7.17M	100.05M	14.96M	16.14M	96.80M	16.61M	62.76M
Additional items
EPS (Basic) (Quarter)	0.05	0.09	0.02	0.04	-0.03	-0.63	-0.02	-0.12	-0.79	-1.25	-7.47	-0.08	-0.07	-1.72	11.83	3.74	-2.95	8.27	1.50	6.70
EPS (Weighted Average and Diluted) (Quarter)	0.05	0.09	0.02	0.04	-0.03	-0.63	-0.02	-0.12	-0.79	-1.25	-7.47	-0.08	-0.07	-1.72	11.12	3.33	-2.95	7.76	1.61	6.52
Shares Outstanding (Weighted Average) (Quarter)	592.79M	592.79M	592.79M	592.79M	646.37M	629.79M	4.23M	43.39M	4.38M	4.43M	4.41M	4.85M	4.91M	4.97M	0.21M	5.67M	5.99M	6.70M	0.14M	6.99M
Shares Outstanding (Diluted Average) (Quarter)	592.79M				658.99M
EBITDA (Quarter)	27.60M	74.46M	15.54M	29.24M	-1.38M	-428.68M	-5.78M	-4.45M	-0.36M	-0.82M	-26.14M	1.45M	5.30M	9.66M	114.21M	80.66M	33.68M	130.37M	30.92M	81.27M
Interest Expenses (Quarter)	1.50M	1.26M	1.94M	1.86M	4.37M	3.40M	2.86M	3.14M	4.84M	4.10M	4.24M	4.44M	5.05M	5.38M	5.05M	6.12M	5.68M	5.45M	4.98M	4.68M
Tax Rate (Quarter)	1.60%	0.61%	-0.95%	0.71%	-452.33%	1.98%	-20.39%	11.63%	16.05%	7.03%	9.76%	-256.58%	22.90%	-177.71%	7.92%	28.66%	31.97%	21.90%	35.86%	18.02%

Research Tools

Developers

Nutex Health Income Statement (2010-2026) | NUTX

Research Tools

Developers

Nutex Health Income Statement (2010-2026) | NUTX

Create an account

Sign In

Reset Password